Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to Pl 3-kinase, respectively

European Journal of Immunology

Volumn 33, Issue 9, 2003, Pages 2557-2566

  Barel, Monique ^a   Balbo, Michelle ^a   Le Romancer, Muriel ^a   Frade, Raymond ^a  

^a INSERM   (France)

Author keywords

B cell; C3d receptor; Epstein Barr virus; Proliferation; Transformation

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD3 ANTIGEN; GLYCOPROTEIN GP 140; NUCLEOLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBUNIT; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD19; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, COMPLEMENT 3D; RNA-BINDING PROTEINS;

EID: 0141539294     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324059     Document Type: Article

References (31)

1. Barel, M., Charriaut, C. and Frade, R., Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji). FEBS Lett. 1981. 136: 111-114.
2. Frade, R., Myones, B. L., Barel, M., Krikorian, L., Charriaut, C. and Ross, G. R., Gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Eur. J. Immunol. 1985. 15: 1192-1197.
3. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. and Fearon, D. T., Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 1984. 81: 4510-4514.
4. Frade, R., Barel, M., Ehlin-Henriksson, B. and Klein, G., Gp140, the C3d receptor (CR2) of human B lymphocytes, is also the EBV receptor. Proc. Natl. Acad. Sci. USA 1985. 82: 1490-1493.
5. Tanner, J., Weis, J., Fearon, D. T., Whang, Y. and Kieff, E., Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 1987. 50: 203-213.
6. Barel, M., Fiandino, A., Delcayre, A. X., Lyamani, F., and Frade, R., Monoclonal and anti-idiotypic anti-EBV/C3d receptor (EBV/C3dR) antibodies detect two distinct binding sites, one for Epstein-Barr virus and one for C3d on gp140 the EBV/C3dR, expressed on human B lymphocytes. J. Immunol. 1988. 141: 1590-1595.
7. Moore, M. D., Cooper, N. R., Tack B. F. and Nemerow, G. R., Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 1987. 8: 9194-9198.
8. Weis, J. J., Toothaker, L. E., Smith, J. A., Weis, J. H. and Fearon, D. T., Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J. Exp. Med. 1988. 167: 1047-1066.
9. Barel, M., Balbo, M. and Frade, R., Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21), which is due to alternative exon usage. Mol. Immunol. 1998. 35: 1025-1031.
10. Hatzfeld, J., Charriaut-Marlangue, C., Levesque, J. P., Barel, M., Stancou, R., Krikorian, L., Hatzfeld, A. and Frade, R., C3 stimulates proliferation of human pre B Raji cells. Ann. Inst. Pasteur/Immunol. 1987. 138: 451-455.
11. Frade, R., Crevon, M. C., Barel, M., Vasquez, A., Krikorian, L., Charriaut, C. and Galanaud, P., Enhancement of human B cell proliferation by antibody to the C3d receptor, the gp140 molecule. Eur J. Immunol. 1985. 15: 73-76.
12. Melchers, F., Erdei, A., Schultz, T. and Dierich, M. P., Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 1985. 317: 264-267.
13. Masucci, M. G., Szigeti, R., Ernberg, I., Hu, C. P., Torsteinsdottir, S., Frade, R. and Klein, E., Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction. Eur. J. Immunol. 1987. 17: 815-820.
14. Carter, R. H., Spycher, M. O., Ng, Y. C., Hoffman, R and Fearon, D. T., Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 1988. 141: 457-463.
15. Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. and Tedder, T. F., The CD19/CD21 signal transducing complex of human B lymphocyte includes the target of antiproliferative antibody-1 and leu-13 molecules. J. Immunol. 1992. 149: 2841-2850.
16. Barel, M., Vasquez, A., Charriaut, C., Aufredou, M. T., Galanaud, P. and Frade, R., Gp140, the EBV/C3d receptor (CR2) is phosphorylated upon in vitro activation of human peripheral B lymphocytes. FEBS Lett. 1986. 197: 353-356.
17. Carel, J. C., Myones, B. L., Frazier, B. and Holers, V. M., Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 1990. 265: 12293-12299.
18. Balbo, M., Barel, M. Bouillie, S., Drané, P., Cassinat, B. and Frade, R., Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2, CD21), regulates B lymphocyte proliferation triggered through CR2. Mol. Immunol. 1995. 32: 1295-1298.
19. Bouillie, S., Barel, M. and Frade, R., Signaling through the EBV/C3d receptor (CR2/CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway. J. Immunol. 1999. 162: 136-143.
20. Tuveson, D. A., Carter, R. H., Soltoff, S. P. and Fearon, D. T., CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993. 260: 986-989.
21. Barel, M., Le Romancer, M. and Frade, R., Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. J. Immunol. 2001. 166: 3167-3173.
22. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A., Discovery of a novel, potent, and src family-selective tyrosine kinase inhibitor. Study of lck- and fyn T-dependent T cell activation. J. Biol. Chem. 1996. 271: 695-701.
23. Oliver, J. M., Burg, D. L., Wilson, B. S., McLaughlin, J. L. and Geahlen, R. L., Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the syk-selective inhibitor, piceatannol. J. Biol. Chem. 1994. 269: 29697-29703.
24. Thomas, S. M. and Brugge, J. S., Cellular functions regulated by src family kinases. Annu. Rev. Cell. Dev. Biol. 1997. 13: 513-605.
25. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R. and Tsichlis, P. N., The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF activated phosphatidylinositol 3-kinase. Cell 1995. 81: 727-736.
26. Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated protein kinase B. Nature 1995. 378: 785-789.
27. Liu, X., Marengere, L. E. M., Koch, C. A. and Pawson, T., The v-src SH3 domain binds phosphatidylinositol 3-kinase. Mol. Cell. Biol. 1993. 213: 5225-5232.
28. Gold, M. R., Scheid, M. P., Santos, L., Dang-Lawson, M., Roth, R. A., Matsuuchi, L., Duronio, V. and Krebs, D. L., The B cell antigen receptor activated the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J. Immunol. 1999. 163: 1894-1905.
29. Bonnefoy, J. Y., Henchoz, S., Hardie, D., Holder, M. J. and Gordon, J., A subset of anti-CD21 antibodies promotes the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 1993. 23: 969-972.
30. Beitz, L. O., Fruman, D. A., Kurosaki, T., Cantley, L. C. and Scharenberg, A. M., Syk is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J. Biol. Chem. 1999. 274: 32662-32666.
31. Pogue, S. L., Kurosaki, T., Bolen, J. and Herbst, R., B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on syk kinase. J. Immunol. 2000. 165: 1300-1306.